In the past week, OCEA stock has gone down by -24.56%, with a monthly decline of -26.09% and a quarterly plunge of -43.33%. The volatility ratio for the week is 9.78%, and the volatility levels for the last 30 days are 6.99% for Ocean Biomedical Inc The simple moving average for the last 20 days is -23.68% for OCEA stock, with a simple moving average of -64.45% for the last 200 days.
Is It Worth Investing in Ocean Biomedical Inc (NASDAQ: OCEA) Right Now?
Moreover, the 36-month beta value for OCEA is 1.42. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OCEA is 10.38M and currently, short sellers hold a 1.56% of that float. On December 20, 2024, OCEA’s average trading volume was 52.15K shares.
OCEA) stock’s latest price update
Ocean Biomedical Inc (NASDAQ: OCEA) has seen a decline in its stock price by -13.41 in relation to its previous close of 0.59. However, the company has experienced a -24.56% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-22 that PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”).
OCEA Trading at -35.26% from the 50-Day Moving Average
After a stumble in the market that brought OCEA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.45% of loss for the given period.
Volatility was left at 6.99%, however, over the last 30 days, the volatility rate increased by 9.78%, as shares sank -25.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -41.82% lower at present.
During the last 5 trading sessions, OCEA fell by -21.60%, which changed the moving average for the period of 200-days by -89.94% in comparison to the 20-day moving average, which settled at $0.6691. In addition, Ocean Biomedical Inc saw -22.73% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for OCEA
The total capital return value is set at 0.19. Equity return is now at value -1691.47, with -196.66 for asset returns.
Based on Ocean Biomedical Inc (OCEA), the company’s capital structure generated -0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -0.56. The debt to equity ratio resting at -0.13. The interest coverage ratio of the stock is -3.2.
Currently, EBITDA for the company is -0.96 million with net debt to EBITDA at -0.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.07.
Conclusion
To wrap up, the performance of Ocean Biomedical Inc (OCEA) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
